Zhejiang Shapuaisi Pharmaceutical (603168.SH): Olodaterol hydrochloride eye drops obtained drug registration certificate
Shapuaisi (603168.SH) announced that the company has received approval from the National Medical Products Administration for the issuance of hydrochloride...
Zhejiang Shapuaisi Pharmaceutical (603168.SH) announced that the company has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops approved and issued by the National Medical Products Administration. The approved Olopatadine Hydrochloride Eye Drops are used to treat eye itching related to allergic conjunctivitis.
Related Articles
Sedge Pharmaceuticals (688266.SH): Injection ZG006 conducted a crucial clinical trial and completed the enrollment of the first subject.
HK Stock Market Move | CHERVON(02285) rose by more than 6%. Institutions are optimistic about its long-term benefits from the repair of the American real estate market.
.png)
Jack Ma "strongly returns" to lead Alibaba (09988) in the AI and food delivery battle.
Sedge Pharmaceuticals (688266.SH): Injection ZG006 conducted a crucial clinical trial and completed the enrollment of the first subject.
HK Stock Market Move | CHERVON(02285) rose by more than 6%. Institutions are optimistic about its long-term benefits from the repair of the American real estate market.
Jack Ma "strongly returns" to lead Alibaba (09988) in the AI and food delivery battle.
